Objective To develop a provisional definition for the evaluation of response to therapy in
juvenile dermatomyositis (DM) based on the Paediatric Rheumatology International Trials …

Objective. We aimed to establish the prevalence and clinical associations of anti-HMG-CoA-reductase
(anti-HMGCR) in a large UK cohort with juvenile myositis. Methods. There were …

Monocyte chemoattractant protein-1 (MCP-1) has a pathogenic role in murine lupus
nephritis (LN). We recruited 25 pediatric and adolescent systemic lupus erythematosus (SLE) …

Objective To develop and validate new classification criteria for adult and juvenile idiopathic
inflammatory myopathies (IIM) and their major subgroups. Methods Candidate variables …

Longâ•’term outcome and prognostic factors of juvenile dermatomyositis: A multinational,
multicenter study of 490 patients Page 1 Long-Term Outcome and Prognostic Factors of …

Background In 2012, a European initiative called Single Hub and Access point for pediatric
Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic …

Objectives IgA vasculitis (IgAV, formerly known as Henoch–Schönlein purpura) is the most
common cause of systemic vasculitis in childhood. To date, there are no internationally …

Objective The UK Juvenile‐Onset Systemic Lupus Erythematosus (JSLE) Cohort Study is a
multicenter collaborative network established with the aim of improving the understanding of …

Background Most data for treatment of dermatomyositis and juvenile dermatomyositis are
from anecdotal, non-randomised case series. We aimed to compare, in a randomised trial, the …

Background In 2012, a European initiative called Single Hub and Access point for pediatric
Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic …